Milwaukee Closes More Schools to Address Lead Crisis
By I. Edwards HealthDay Reporter
WEDNESDAY, April 30, 2025 — Milwaukee will temporarily close two more elementary schools as it works to tackle a lead crisis in its public school buildings.
The school district announced Monday that Westside Academy and Brown Street School will close for repairs. Two other schools — Starms Early Childhood Education Center and LaFollette School — had already been closed. So far, nine schools have been flagged for lead hazard work, and students are being moved while repairs are being made, CNN reported.
The city’s school district and health department are checking about 100 schools built before 1978, when lead was banned in paint. They expect inspections and repairs to continue through the summer.
Superintendent Brenda Cassellius said 54 schools built before 1950 are scheduled to be cleaned before the next school year. Another 52 schools built between 1950 and 1978 are expected to be cleaned by year's end.
“We are asking families to remain vigilant and to please have their children tested for lead exposure,” Cassellius said. Families can use their doctor or pop-up clinics organized by the city.
Lead is dangerous even at low levels. High levels can cause nausea, vomiting and seizures. Lower levels can harm a child’s brain, affecting learning, attention and behavior, CNN reported.
The district's new plan starts with a visual inspection of every building. Schools are then rated as low, medium or high risk. Those at medium or high risk will get extra testing and may need full or partial closures for cleanup.
The district is also creating a plan to test adults who work in the buildings, like custodians.
The city had been working with the U.S. Centers for Disease Control and Prevention (CDC) on a testing plan, but that support ended after the CDC’s Lead Poisoning Prevention Program was cut. The CDC also turned down Milwaukee's request for emergency help from epidemiologists, due to the cuts.
“Obviously, in this case, we no longer had the expertise at CDC to support that request,” Eric Pevzner, chief of the CDC’s epidemiology and laboratory branch, told CNN.
Wisconsin Sen. Tammy Baldwin and U.S. Rep. Gwen Moore recently urged U.S. health officials to restore CDC lead experts, writing, “You have the ability to immediately rectify this issue, and we urge you to do so."
The crisis came to light after a student tested positive for high lead levels late last year. No major sources were found in the child’s home, but peeling lead paint and lead dust were found in the child's school.
Since then, three more students with elevated lead levels have been reported, though it’s unclear if their schools are the source, CNN said.
“As everyone understands, when we do receive a referral or a complaint, we have to discern whether it’s a poisoning from their home or a secondary address affiliated with that family, or if it’s tied to the school, so those investigations can take a lot of time,” Michael Totoraitis, Milwaukee’s commissioner of health, said.
He also explained that acute exposure to lead, like eating flaking paint, usually shows up in blood tests within a month. Chronic exposure, like breathing lead dust, takes longer to appear.
“It might be kind of scary, but we have a really good track record of seeing those levels come down if they do test high,” Totoraitis added.
Usually, only babies are screened for lead at 1 and 2 years of age, but the city is considering expanding screening to older children. Milwaukee schools and the health department are offering school-based lead testing clinics, with the next one scheduled for May 7.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-05-01 06:00
Read more

- Fasting Outperforms Calorie Cutting, Clinical Trial Says
- Tolebrutinib Phase 3 Data Published in NEJM Demonstrate Benefit on Disability Progression in Multiple Sclerosis
- Pregnancy Might Offer Protection Against Long COVID
- More Kids Without Asthma Inhaler After Popular Product Taken Off Market
- No Greater Risk Of Brain Aging Among People With Autism
- Rinvoq (upadacitinib) Receives U.S. FDA Approval for Giant Cell Arteritis (GCA)
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions